Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Updated June 2026
Oral semaglutide 25mg achieved average weight loss of 16.6% at 64 weeks, while orforglipron 36mg achieved 12.4% at 72 weeks
-(1).png?sfvrsn=c236e848_3)
For non-diabetic patients whose insurance denies coverage entirely, the cash-pay options are the same as for everyone else: NovoCare ($149 to $349/month), LillyDirect ($299 to $449/month), or patient assistance programs if income-eligible
Despite this competition, Novo reaped a bonanza
Regular reassessment with healthcare providers helps determine the ongoing need for treatment, with consideration of factors such as treatment response, side effects, and changes in health status or treatment goals
It binds phosphorus in the gut, limiting absorption, but evidence is limited
US$ 25.97
US$ 23.93
US$ 23.86
US$ 29.80
US$ 28.03
US$ 27.55
